Killing Cancer: Immunotherapy for Leukemia and Lymphoma, with Ronald Levy

On January 19, 2016, Ronald Levy, M.D., the Robert K. Summy and Helen K. Summy Professor of Medicine and Director of the Lymphoma Program at Stanford University School of Medicine, discussed current immunotherapy treatment options for patients with leukemia and lymphoma, such as monoclonal antibodies, chimeric antigen receptor (CAR) therapy, checkpoint blockade, and combination therapies, and how close we are to making these treatments available to more patients. Dr. Levy's slides are available for download at bit.ly/RonLevySlides

Cancer Research Institute's new webinar series, "Cancer Immunotherapy and You," are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This series was made possible by the generous support of LabAnswer and its employees, Celldex Therapeutics, and Regeneron. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.